Literature DB >> 17613961

Buprenorphine misuse in Finland.

Mauri Aalto, Jukka Halme, Jukka-Pekka Visapää, Mikko Salaspuro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17613961     DOI： 10.1080/10826080701434857

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN： 1082-6084            Impact factor:   2.164


× No keyword cloud information.
  10 in total

1.  Buprenorphine treatment for narcotic addiction: not without risks.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Innov Clin Neurosci       Date:  2015 Mar-Apr

2.  Shifting blame: Buprenorphine prescribers, addiction treatment, and prescription monitoring in middle-class America.

Authors:  Sonia Mendoza; Allyssa S Rivera-Cabrero; Helena Hansen
Journal:  Transcult Psychiatry       Date:  2016-08-03

Review 3.  Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review.

Authors:  Michael A Yokell; Nickolas D Zaller; Traci C Green; Josiah D Rich
Journal:  Curr Drug Abuse Rev       Date:  2011-03

4.  Urinary excretion of buprenorphine, norbuprenorphine, buprenorphine-glucuronide, and norbuprenorphine-glucuronide in pregnant women receiving buprenorphine maintenance treatment.

Authors:  Sherri L Kacinko; Hendree E Jones; Rolley E Johnson; Robin E Choo; Marta Concheiro-Guisan; Marilyn A Huestis
Journal:  Clin Chem       Date:  2009-03-26       Impact factor: 8.327

5.  A liquid chromatography tandem mass spectrometry method for the simultaneous quantification of 20 drugs of abuse and metabolites in human meconium.

Authors:  Teresa R Gray; Diaa M Shakleya; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2009-02-26       Impact factor: 4.142

6.  Development and validation of a liquid chromatography-tandem mass spectrometry assay for the simultaneous quantification of buprenorphine, norbuprenorphine, and metabolites in human urine.

Authors:  Sherri L Kacinko; Marta Concheiro-Guisan; Diaa M Shakleya; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2008-08-30       Impact factor: 4.142

7.  Challenges in implementing opioid agonist therapy in Lebanon: a qualitative study from a user's perspective.

Authors:  Ali Ghaddar; Sanaa Khandaqji; Zeinab Abbass
Journal:  Subst Abuse Treat Prev Policy       Date:  2018-04-19

8.  Non-prescribed use of methadone and buprenorphine prior to opioid substitution treatment: lifetime prevalence, motives, and drug sources among people with opioid dependence in five Swedish cities.

Authors:  Björn Johnson; Torkel Richert
Journal:  Harm Reduct J       Date:  2019-05-02

Review 9.  Patterns of use and adverse events reported among persons who regularly inject buprenorphine: a systematic review.

Authors:  Nikki Bozinoff; Vitor Tardelli; Dafna Sara Rubin-Kahana; Bernard Le Foll
Journal:  Harm Reduct J       Date:  2022-10-13

10.  The Experience of the Treatment Demand Indicator in Europe: A Common Monitoring Tool Across 30 Countries.

Authors:  Linda Montanari; Alessandro Pirona; Bruno Guarita; Dagmar Hedrich; Jane Mounteney; Julian Vicente
Journal:  J Stud Alcohol Drugs Suppl       Date:  2019-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.